Day 1 – 16 November 2011
MORNING PLENARY SESSIONS
How To Implement The EMA Guideline On Bioanalytical Method Validation
Chair and Moderator: Silke Luedtke (Boehringer-Ingelheim)
Peter van Amsterdam (on behalf of EBF)
Olivier Le Blaye (afssaps)
< Title to be confirmed >
Timothy Sangster (Charles River Laboratories)
EMA – have our prayers been answered!
Daniela Stoellner (Novartis)
New EMA guideline on method validation and how it translates into best practice for Ligand Binding Assays
Graeme Smith (Huntingdon Life Sciences)
Partial Validation when is enough, enough?
Morten Rohde (Lundbeck)
Matrix Effects in Bioanalysis, when established procedures become obsolete.
To download the full program, follow this link.